Development of physiologically‐based pharmacokinetic models for standard of care and newer tuberculosis drugs-Reference-Cited by-同舟云学术

Development of physiologically‐based pharmacokinetic models for standard of care and newer tuberculosis drugs

Published:2021-10-08 Issue:11 Volume:10 Page:1382-1395
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst Pharmacol

Author:

Humphries Helen¹^ORCID,Almond Lisa¹,Berg Alexander²,Gardner Iain¹,Hatley Oliver¹^ORCID,Pan Xian¹^ORCID,Small Ben¹^ORCID,Zhang Mian¹,Jamei Masoud¹^ORCID,Romero Klaus²

Affiliation:

1. Certara UK Limited, Simcyp Division Sheffield UK

2. Critical Path Institute Tucson Arizona USA

Funder

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12707

Reference46 articles.

1. Origins of combination therapy for tuberculosis: lessons for future antimicrobial development and application;Kerantzas CA;mBio,2017

2. Current and future treatments for tuberculosis

3. Recent Advances in Development and Application of Physiologically-Based Pharmacokinetic (PBPK) Models: a Transition from Academic Curiosity to Regulatory Acceptance

4. Advancing tuberculosis drug regimen development through innovative quantitative translational pharmacology methods and approaches

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. stormTB: A web-based simulator of a murine minimal-PBPK model for anti-tuberculosis treatments;2024-07-08

2. A minimal PBPK model to accelerate preclinical development of drugs against tuberculosis;Frontiers in Pharmacology;2024-01-04

3. Development and application of a PBPK modeling strategy to support antimalarial drug development;CPT: Pharmacometrics & Systems Pharmacology;2023-08-16

4. Physiologically Based Pharmacokinetic Modeling to Determine the Impact of CYP2B6 Genotype on Efavirenz Exposure in Children, Mothers and Breastfeeding Infants;Clinical Pharmacology & Therapeutics;2023-05-10

5. PBPK modeling of ivermectin—Considerations for the purpose of developing alternative routes to optimize its safety profile;CPT: Pharmacometrics & Systems Pharmacology;2023-03-15